NewsRoom Articles - Page 327 of 1390

TuesdayMar 29, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Provides Update on Advances in Brain Cancer Drugs and Operational Financials

Texas-based CNS Pharmaceuticals is a novel brain cancer drug developer that is building a series of global clinical trials for its lead drug candidate, Berubicin CNS began dosing patients in a global trial last September to evaluate Berubicin in treating glioblastoma multiforme (“GBM”), currently an incurable brain cancer CNS received FDA Fast Track designation for Berubicin in June 2021 and FDA Orphan Drug designation for Berubicin in June 2020 Berubicin is a novel anthracycline capable of crossing the blood-brain barrier The company received approval from Switzerland’s swissethics organization for Berubicin trials there, boosting CNS’s efforts at a global response to…

TuesdayMar 29, 2022 9:00 am

Correlate Infrastructure Partners Inc. (CIPI) Is ‘One to Watch’

CIPI closed on acquisitions of subsidiaries Correlate and Solar Site Design on December 28, 2021 The company has filed with the SEC to change its name to Correlate Infrastructure Partners Inc. CIPI subsidiaries have a project pipeline of over $100 million, with more than $20 million in awarded backlog The company’s total addressable market is more than 5.9 million commercial buildings in U.S., representing a market value of $290 billion in 2022 Correlate Infrastructure Partners (OTCQB: CIPI), formerly Triccar Inc., through its two subsidiaries, Correlate and Solar Site Design, offers a complete suite of proprietary clean energy assessment and fulfilment…

TuesdayMar 29, 2022 9:00 am

Smarter Homes, Smarter Cars, Smarter People

NetworkNewsWire Editorial Coverage: The Internet of Things (“IoT”) has evolved over the last couple decades, weaving its way into daily life by providing increased utility and functionality for everyday items. Broadly speaking, IoT refers to the overarching technology that connects physical items (e.g., refrigerators, door locks, HVAC) to the internet so they can be controlled from a mobile or desktop app to provide real-time controls and data analysis. Delivering convenience and savings, many of these interconnected devices have become readily available and affordable with an estimated 46 billion connected devices in the world today. That may sound like a lot,…

TuesdayMar 29, 2022 9:00 am

Hero Technologies Inc. (HENC) CEO Talks ‘Foot in the Door’ Acquisitions in Recent Bell2Bell Podcast

HENC is focusing on expansion of current operations, future growth in industry Company aims to be a low-cost, nationally and internationally branded company, become true multistate operator (“MSO”) Recent podcast provides overview of company’s strategic plans, important milestones Key acquisitions and investments have played an essential role in Hero Technologies’ (OTC: HENC) strategic business plan and operations. As a featured guest during a recent episode of the Bell2Bell Podcast (https://nnw.fm/LUcyo), company CEO Gina Serkasevich discussed HENC’s careful expansion moves. In 2020, “both Highly Relaxing and the assets of V Brokers, under Veteran Hemp Co., were acquired,” said Serkasevich as she discussed…

MondayMar 28, 2022 9:15 am

Kronos Advanced Technologies Inc. (OTC: KNOS) Air Purifier Features Most Effective Technology Available

Air purifiers can improve indoor air quality, help soothe allergy and asthma symptoms, and rid air of toxins. Kronos’s proprietary, medical-grade technology has been tested as the most effective clean-air solution on the market. An air purifier “may be the household investment to make this year” (“USA Today”) The global pandemic has drawn attention to the fact that airborne particles can be dangerous, even life threatening. Kronos Advanced Technologies (OTC: KNOS) has developed one of the most effective air purifiers available today. One study attributed over two million deaths annually to indoor air pollution (https://nnw.fm/afMbo). Air purifiers are part of…

MondayMar 28, 2022 9:15 am

DGE’s 2nd Real World Evidence and Market Access Symposium to Access High Quality Data to Meet the Patient Needs

Life science executives are invited to attend the 2nd Real World Evidence and Market Access Symposium being held as a virtual event on April 11-12, 2022. The event is hosted by DGE, a leading global event management company that caters to the dynamic informational and networking needs of the pharmaceutical, biotechnology, health care, medical devices, and allied industries. The event centers around discussions, keynotes and sessions about the latest advances and best practices for harnessing real-world data insights that are productive for patients, payers and providers. Organizations can strengthen their business and reimbursement strategies by identifying and accessing the correct…

MondayMar 28, 2022 9:00 am

Delic Holdings Corp’s (CSE: DELC) (OTCQB: DELCF) Co-Founder and CEO Offers a Glimpse into the Company’s History and Future on The Jesse Tee Show

While appearing on The Jesse Tee Show, the company’s co-founder and CEO, Matt Stang, shared his professional background, Delic’s history, its growth, and its plans going forward Mr. Stang attributes its success to understanding where opportunities and people connect, how to make things win-win for all people, and giving customers value Founded in 2016, Delic Holdings Corp now has a market cap of $4.32 million as of March 2022 Delic Holdings (CSE: DELC) (OTCQB: DELCF) has been at the forefront of reframing the psychedelic conversation. It has also remained committed to bringing science-backed benefits of psychedelics to the health industry,…

MondayMar 28, 2022 9:00 am

Autonomous Security Robot Developer Knightscope Inc. (NASDAQ: KSCP) Explains IP Advantage as Nasdaq Listing Gains Attention

Artificial intelligence-enhanced security devices and big data collection are gaining popularity as means for strengthening companies’ footprints, particularly in response to criminal activity that can otherwise weaken operations Knightscope is a Silicon Valley-based company developing Autonomous Security Robots (“ASRs”) in response to America’s security needs, delivering a variety of models that observe and report on activity at client properties using powerful technological services Knightscope completed public listing on the Nasdaq Exchange in January 2022, enhancing awareness of its products and generating new inquiries about the nature of its services The company has taken note of its successes with its clients,…

MondayMar 28, 2022 9:00 am

Psychedelic Medicine Researcher Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Readies IND Application to Advance Drug Trials

Novel drug development company Mydecine Innovations Group is focusing on a medicinal pipeline for psychedelic drug candidates that have established some efficacy in treating mental illnesses — specifically addiction Mydecine is progressing in its clinical trial evaluation of its lead candidate, MYCO-001, and is finalizing an IND application with the FDA to begin patient dosing for its planned Phase 2 trials The company is targeting nicotine addiction in tobacco smokers Mydecine is also advancing its evaluation of other drug candidates with pending patents to enhance its existing products Medical-use psychedelic drug product developer Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF)…

FridayMar 25, 2022 2:30 pm

The Virtual Growth Conference By M-Vest Events to Offer a Powerful Networking Stage

Fintech, Healthcare, pharma, technology, finance, infrastructure, and allied companies and investors are invited to attend the Virtual Growth Conference, being held on March 28-30, 2022, as a virtual event. The year 2022 opens up opportunities for traders and investors and this Virtual Growth Conference 2022 offers the perfect stage for networking and understanding the future scope of business. The Virtual Growth Conference is one of the leading investor conferences, organized by M-Vest Events, powered by the Maxim Group LLC, a leading investment bank. The group serves investors, issuers and industry stalwarts, allowing them to interact on an excellent online forum.…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Provides Update on Advances in Brain Cancer Drugs and Operational Financials

Correlate Infrastructure Partners Inc. (CIPI) Is ‘One to Watch’

Smarter Homes, Smarter Cars, Smarter People

Hero Technologies Inc. (HENC) CEO Talks ‘Foot in the Door’ Acquisitions in Recent Bell2Bell Podcast

Kronos Advanced Technologies Inc. (OTC: KNOS) Air Purifier Features Most Effective Technology Available

DGE’s 2nd Real World Evidence and Market Access Symposium to Access High Quality Data to Meet the Patient Needs

Delic Holdings Corp’s (CSE: DELC) (OTCQB: DELCF) Co-Founder and CEO Offers a Glimpse into the Company’s History and Future on The Jesse Tee Show

Autonomous Security Robot Developer Knightscope Inc. (NASDAQ: KSCP) Explains IP Advantage as Nasdaq Listing Gains Attention

Psychedelic Medicine Researcher Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Readies IND Application to Advance Drug Trials

The Virtual Growth Conference By M-Vest Events to Offer a Powerful Networking Stage

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search